Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02084290 · ClinicalTrials.gov registry record · NA
Evaluating a Shared Decision Making Program for Crohn's Disease
A NA study of Crohn's Disease, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 204
- Enrollment target
- 14
- Study locations
NCT02084290 is a NA study of Crohn's Disease that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 204 participants, below the 2,393-participant average among 105 other Crohn's Disease trials with a reported enrollment target (91% lower). The trial reports 14 study locations across 11 states.
The verdict
NCT02084290, a NA study of Crohn's Disease, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 204 participants
- Enrollment target
- 14
- Study locations
Study Summary
Specific Aim: Study the impact of the Crohn's Disease Shared Decision Making Program on patients' treatment choice, persistence with chosen therapy, decision quality, cost of care, and outcomes Hypothesis: The Crohn's Disease Shared Decision Making Program will help patients understand which treatments are right for them and will lead to a higher acceptance of appropriate therapy, improved persistence with chosen therapy, lower costs and improved clinical outcomes. To accomplish this aim, Investigators will perform a randomized controlled trial to: 1. Determine how the shared decision making program influences patients' choice of therapy 2. Evaluate how the shared decision making program affects persistence with chosen therapy 3. Determine how the shared decision making program affects decision quality 4. Determine how the shared decision making program influences cost of care and clinical outcomes Expected Outcome and Impact: Investigators expect that this program will influence patients' choice of therapy, persistence with their preferred therapy, and lead to improved clinical outcomes. Investigators believe that this product can be successfully operationalized in the clinic to establish a new paradigm of how providers can communicate personalized treatment options to patients across a broad range of diseases.
Conditions Studied
Interventions
- BEHAVIORAL Shared Decision Making Program
Study Locations (14)
New York
- Long Island Clinical Research Associates, LLP - Great Neck
- Winthrop University Hospital - Mineola
- Mount Sinai Medical Center - New York
Pennsylvania
- Thomas Jefferson University - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
California
- Cedars-Sinai Medical Center - Los Angeles
Georgia
- Atlanta Gastroenterology Associates - Atlanta
Illinois
- University of Chicago - Chicago
Maryland
- University of Maryland Medical Center - Baltimore
Massachusetts
- Brigham and Women's Hospital - Chestnut Hill
Minnesota
- Minnesota Gastroenterology - Plymouth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2014-03 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02084290
The ClinicalTrials.gov registry entry for NCT02084290 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,393-participant average among 105 other Crohn's Disease trials with a reported enrollment target (91% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Crohn's Disease appearing as the primary indexed condition, and to 1 intervention - of which Shared Decision Making Program is the first listed.
NCT02084290 reports 14 study locations spanning 11 distinct geographic areas - top geographies include New York, Pennsylvania, California.
Frequently Asked Questions
What is clinical trial NCT02084290 about?
NCT02084290 is a clinical study titled "Evaluating a Shared Decision Making Program for Crohn's Disease". Specific Aim: Study the impact of the Crohn's Disease Shared Decision Making Program on patients' treatment choice, persistence with chosen therapy, decision quality, cost of care, and outcomes Hypothesis: The Crohn's Disease Shared Decision Making Program will help patients understand which treatm...
What is the current status of trial NCT02084290?
This trial is currently completed. It is a NA study. The enrollment target is 204 participants. The study started on 2014-03. Estimated completion is 2018-12-31.
What conditions does trial NCT02084290 study?
This clinical trial studies the following conditions: Crohn's Disease.
What interventions are being tested in trial NCT02084290?
The interventions under investigation include: Shared Decision Making Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02084290?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02084290 being conducted?
This trial has 14 study locations across California, Georgia, Illinois, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease
RECRUITING · NA
-
Behavioral Therapy for Crohn's Disease
RECRUITING · NA
-
Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
RECRUITING · NA
-
Dietary Therapy and Gut Microbiome in Crohn's Disease and Ulcerative Colitis
ACTIVE NOT RECRUITING · NA
-
Improving Medication Adherence in Pediatric Inflammatory Bowel Disease
COMPLETED · NA
-
Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of Life
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.